About the Company
We do not have any company description for Scinai Immunotherapeutics Ltd. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd. (SCNI) Q2 2024 Earnings Call Transcript
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) Q2 2024 Results Conference Call August 20, 2024 11:00 AM ETCompany ParticipantsLiat Halpert - Head of Business ...
BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd ...
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological ...
Scinai Announces Annual Financial Results for 2024
JERUSALEM, May 7, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing novel and innovative biological ...
Scinai Immunotherapeutics CEO Issues Letter to Shareholders
JERUSALEM, Jan. 4, 2024/ PRNewswire/-- Scinai Immunotherapeutics Ltd., a biopharmaceutical company focused on development of inflammation and immunology biological products, today published a ...
SCNI | Scinai Immunotherapeutics Ltd. ADR Profile | MarketWatch
Company Profile Scinai Immunotherapeutics Ltd. ADR Jerusalem BioPark Hadassah Ein Kerem Campus 2nd Floor Jerusalem, JM 74036 Phone972 302 930-2529 IndustryPharmaceuticals SectorHealth Care/Life ...
SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE ...
Scinai Immunotherapeutics Ltd. is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic ...
Scinai Immunotherapeutics Ltd ADR SCNI - Morningstar
Find out if Scinai Immunotherapeutics Ltd ADR (SCNI:XNAS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value of ...
Scinai Immunotherapeutics Ltd. ADR (SCNI) Stock Price Today - WSJ
View the latest Scinai Immunotherapeutics Ltd. ADR (SCNI) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Scinai Immunotherapeutics Short Interest Report - Benzinga
Short interest in Scinai Immunotherapeutics Ltd (NASDAQ:SCNI) decreased during the last reporting period, falling from 4.95K to 430.00. This put 0.15% of the company's publicly available shares short.
BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd ...
Scinai Immunotherapeutics to debut tomorrow under Nasdaq ticker symbol “SCNI” News provided by BiondVax Pharmaceuticals Ltd. Sep 06, 2023, 6:00 AM ET ...
Scinai Immunotherapeutics Ltd ADR SCNI - Morningstar
Review Scinai Immunotherapeutics Ltd ADR (SCNI:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.
Similar Companies
Loading the latest forecasts...